A detailed history of Saba Capital Management, L.P. transactions in Embecta Corp. stock. As of the latest transaction made, Saba Capital Management, L.P. holds 379,209 shares of EMBC stock, worth $5.06 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
379,209
Previous 52,500 622.3%
Holding current value
$5.06 Million
Previous $669,000 449.18%
% of portfolio
0.09%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$9.28 - $13.3 $3.03 Million - $4.35 Million
326,709 Added 622.3%
379,209 $3.67 Million
Q1 2025

May 15, 2025

BUY
$12.28 - $20.93 $644,700 - $1.1 Million
52,500 New
52,500 $669,000
Q2 2024

Aug 14, 2024

BUY
$10.13 - $14.6 $1.61 Million - $2.32 Million
158,831 New
158,831 $1.99 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $772M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Saba Capital Management, L.P. Portfolio

Follow Saba Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saba Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Saba Capital Management, L.P. with notifications on news.